Risk factors for surgical site infections after breast surgery: A systematic review and meta-analysis

European Journal of Surgical Oncology

Volumn 38, Issue 5, 2012, Pages 375-381

  Xue, D Q ^a   Qian, C ^b   Yang, L ^a   Wang, X F ^a  

^a SOOCHOW UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Breast surgery; Breast surgical site infections; Meta analysis; Risk factor

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID;

ANTIBIOTIC THERAPY; BODY MASS; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DRUG USE; HUMAN; HYPERTENSION; LYMPH NODE DISSECTION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SURGICAL INFECTION; SYSTEMATIC REVIEW;

AGE FACTORS; BIOPSY; BLOOD LOSS, SURGICAL; BODY MASS INDEX; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; DIABETES COMPLICATIONS; HEMATOMA; HUMANS; HYPERTENSION; INCIDENCE; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; ODDS RATIO; REOPERATION; RISK FACTORS; SEROMA; SUCTION; SURGICAL WOUND INFECTION;

EID: 84862831094     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.02.179     Document Type: Review

References (38)

1. Hughes WT, Flynn PM, Williams BG. Nosocomial infections in patients with neoplastic diseases. In: Mayhall CG, editor. Hospital Epidemiology and infections control. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1999, p. 767-71.
2. Robstein C, Ferguson R, Cummings KM, et al. Determinants of clean surgical wound infections for breast procedures at an oncologic centre. Infect Control Hosp Epidemiol 1992;79:314-7.
3. Gaynes RP, Culver DH, Horan TC, et al. Surgical site infections (SSI) rates in the United States, 1992e1998: the national nosocomial infections surveillance system basic SSI risk index. Clin Infect Dis 2001 Sep 1;33(Suppl. 2):S69-77. (Pubitemid 32762924)
4. Hall JC, Hall JL. Antibiotic prophylaxis for patients undergoing breast surgery. J Hosp Infect 2000;46:165-70.
5. Canavese G, Catturich A, Vecchio C, et al. Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer: results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol 1997;23:10-2. (Pubitemid 27107485)
6. National Nosocomial Infections Surveillance System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85.
7. Sørensen LT, Hørby J, Friis E, et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002 Dec;28(8):815-20. (Pubitemid 35402290)
8. Platt R, Zucker JR, Zaleznik DF, et al. Prophylaxis against wound infection following herniorrhaphy or breast surgery. J Infect Dis 1992; 166:556-60.
9. Vandeweyer E, Deraemaecker R, Nogaret JM, et al. Immediate breast reconstruction with implants and adjuvant chemotherapy: a good option? Acta Chir Belg 2003;103:98-101. (Pubitemid 38340208)
10. Cunningham M, Bunn F, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev 2006 Apr;19(2):CD005360.
11. Rotstein C, Ferguson R, Cummings KM, et al. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect Control Hosp Epidemiol 1992;13:207-14.
12. Vinton AL, Traverso LW, Zehring RD. Immediate breast reconstruction following mastectomy is as safe as mastectomy alone. Arch Surg 1990;125:1303-8. (Pubitemid 20360790)
13. Bertin ML, Crowe J, Gordon SM. Determinants of surgical site infections after breast surgery. Am J Infect Control 1998 Feb;26(1):61-5. (Pubitemid 28093906)
14. Rey JE, Gardner SM, Cushing RD. Determinants of surgical site infections after breast biopsy. Am J Infect Control 2005 Mar;33(2):126-9. (Pubitemid 40283476)
15. Gao YX, Xu L, Ye JM, et al. Analysis of risk factors of surgical site infections in breast cancer. Chin Med J (Engl) 2010 Mar 5;123(5):559-62.
16. Brewer VH, Hahn KA, Rohrbach BW, et al. Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin Infect Dis 2000 Sep;31(3):654-9.
17. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 1999;20:250-80.
18. Vilar-Compte D, Rosales S, Hernandez-Mello N, et al. Surveillance, control, and prevention of surgical site infections in breast cancer surgery: a 5-year experience. Am J Infect Control 2009 Oct;37(8):674-9.
19. Olsen MA, Lefta M, Dietz JR, et al. Risk factors for surgical site infections after major breast operation. J Am Coll Surg 2008 Sep;207(3): 326-35. [Epub 2008 Jun 26].
20. Vilar-Compte D, Jacquemin B, Robles-Vidal C, et al. Surgical site infections in breast surgery: case-control study. World J Surg 2004 Mar; 28(3):242-6. (Pubitemid 38375522)
21. Vilar-Compte D, Roldán-Marín R, Robles-Vidal C, et al. Surgical site infections (SSI) rates among patients who underwent mastectomy after the introduction of SSI prevention policies. Infect Control Hosp Epidemiol 2006 Aug;27(8):829-34. (Pubitemid 44320334)
22. Zhou WB, Ding Q, Chen L, et al. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials. Breast Cancer Res Treat 2011 Aug;128(3):625-31.
23. Zhou WB, Liu XA, Dai JC, et al. Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast. Can J Surg 2011 Oct;54(5):300-6.
24. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127(9):820-6. (Pubitemid 27465551)
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959 Apr;22(4):719-48.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 Sep;7(3):177-88. (Pubitemid 17189972)
27. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. (Pubitemid 27387172)
28. Ruvalcaba-Limón E, Robles-Vidal C, Poitevin-Chacón A, et al. Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case-control analysis. Breast Cancer Res Treat 2006 Jan;95(2):147-52.
29. Chang DW, Reece GP, Wang B, et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg 2000 Jun;105(7):2374-80. (Pubitemid 30351115)
30. Zimmermann NE, Dahl MB, Graversen HP. Effects of tobacco smoking on the incidence of flap necrosis after mastectomy. Ugeskr Laeger 1997 Aug 11;159(33):4974-6. (Pubitemid 127712226)
31. Broadwater JR, Edwards MJ, Kuglen C, et al. Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. Ann Surg 1991 Feb;213(2):126-9.
32. McGonigal MD, Martin DM, Lucas CE, et al. The effects of breast cancer chemotherapy on wound healing in the rat. J Surg Res 1987; 42:560-4. (Pubitemid 17091905)
33. Bland KI, Palin WE, von Fraunhofer JA, et al. Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 1984;199:782-90. (Pubitemid 14112399)
34. Shamberger R. Effect of chemotherapy and radiotherapy on wound healing. Recent Results Cancer Res 1985;98:17-34.
35. Raaf JH. Techniques for avoiding surgical complications in chemotherapy treated cancer patients. Recent Results Cancer Res 1985;98: 46-52.
36. Mathes SJ, Alexander J. Radiation injury. Surg Oncol Clin N Am 1996; 5:809-24. (Pubitemid 26353433)
37. Penel N, Yazdanpanah Y, Chauvet MP, et al. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol 2007 Aug 1;96(2):124-9.
38. Felippe WA, Werneck GL, Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg 2007 Dec;31(12):2293-9. (Pubitemid 350231481)